The company's share price fall is justified by its fundament...
The company's share price fall is justified by its fundamental deterioration. It needs to return to revenue growth to regain investor enthusiasm. Last year's performance may indicate unresolved challenges, as it was worse than the annualised loss of 6% over the last half decade.
Shareholders in Xiangxue PharmaceuticalLtd (SZSE:300147) Have Lost 49%, as Stock Drops 12% This Past Week
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment